Stocks / PTGX / Shares Outstanding

Protagonist Therapeutics, Inc. Shares Outstanding 2014–2025

Protagonist Therapeutics, Inc. reported 62.6M of shares outstanding for fiscal 2025. That was 2.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +43.1%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details.

Latest filed value
62.6M
One-year change
+2.5%
Change since 2020
+43.1%
Latest period end
2025-12-31
Protagonist Therapeutics, Inc. Shares Outstanding history from 2014 to 2025FY 2014: 0FY 2015: 272409FY 2016: 16722280FY 2017: 21088306FY 2018: 23187219FY 2019: 27217649FY 2020: 43745465FY 2021: 47838330FY 2022: 49339252FY 2023: 57708613FY 2024: 61035139FY 2025: 62577897
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearShares OutstandingChange (YoY)
FY 202562.6M+2.5%
FY 202461.0M+5.8%
FY 202357.7M+17.0%
FY 202249.3M+3.1%
FY 202147.8M+9.4%
FY 202043.7M+60.7%
FY 201927.2M+17.4%
FY 201823.2M+10.0%
FY 201721.1M+26.1%
FY 201616.7M+6038.7%
FY 20150.3M—
FY 20140.0M—

Source: Protagonist Therapeutics, Inc. SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PTGX 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

Protagonist Therapeutics, Inc. reported 62.6M of shares outstanding for fiscal 2025. That was 2.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +43.1%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for Protagonist Therapeutics, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Protagonist Therapeutics, Inc. — frequently asked questions

What is Protagonist Therapeutics, Inc.'s shares outstanding?

Protagonist Therapeutics, Inc. (PTGX) reported shares outstanding of 62.6M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Protagonist Therapeutics, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.

More PTGX financial history

PTGX revenuePTGX net incomePTGX gross profitPTGX eps (earnings per share)PTGX ebitdaPTGX free cash flowPTGX total debtPTGX dividend historyPTGX p/e ratio

Full PTGX fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →